NCT03624218

Brief Summary

The study evaluates the effectiveness of Prolonged Exposure Therapy on a population of individuals with spinal cord injuries. Participants will be randomly assigned to either a treatment as usual or Prolonged Exposure therapy group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 10, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2021

Completed
4.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2026

Completed
Last Updated

January 23, 2026

Status Verified

January 1, 2026

Enrollment Period

3.1 years

First QC Date

July 25, 2018

Last Update Submit

January 22, 2026

Conditions

Keywords

PTSDSCIPEProlonged Exposure

Outcome Measures

Primary Outcomes (1)

  • The PTSD Symptom Scale - Interview for DSM-5 (PSSI-5)

    The PSSI-5 is a 24-item, semi-structured interview that assesses PTSD symptoms in the past two weeks, and makes a diagnostic determination based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria. The interviewer rates participant responses to symptom questions on a 5-point scale of frequency and severity, from 0 ("Not at all") to 4 ("6 or more times a week/severe") with a higher total score meaning more Posttraumatic stress symptoms.

    Used to assess change in Posttraumatic Stress entomology at Baseline, 6 week, 10 week, and 32 week about their past two week experiences.

Secondary Outcomes (10)

  • The MINI International Neuropsychiatric Interview (MINI)

    Assessed at Baseline about past month and lifetime experiences.

  • The Beck Depression Inventory-II (BDI-II)

    Assessed at Baseline, at every Prolonged Therapy Session, 6 week, 10 week, and 32 week about their past month experiences.

  • Post-Traumatic Cognitions Inventory (PTCI)

    Assessed at Baseline, at every Prolonged Therapy Session, 6 week, 10 week, and 32 week about their past month experiences.

  • Numerical Rating Scale (NRS)

    Assessed at Baseline,10 week, and 32 week about their past week experience.

  • Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)

    Assessed at Baseline,10 week, and 32 week about their past month experience.

  • +5 more secondary outcomes

Study Arms (2)

Treatment as Usual

NO INTERVENTION

Participants in the control arm will not receive the PE therapy, but they will rather receive the standard clinical treatment receive by all SCI patients at BIR. This includes an evaluation by a licensed psychologist and continued follow-up psychotherapy as needed. This therapy does not consist of trauma-focused therapy and will be summarized in the analysis as a part of standard of care. TAU participants will have a posttreatment assessment, as well as follow-up assessments at one and 6 months

Intervention

EXPERIMENTAL

Participants randomized to the PE intervention will receive 2-3, 60-minute sessions each week for 4-6 weeks (12 total sessions). Treatment is manualized, and includes education about common reactions to trauma, breathing retraining, prolonged (repeated) imaginal exposure to trauma memories, repeated in vivo exposure to situations that participants are avoiding due to trauma-related fear, and discussion of thoughts and feelings related to exposure exercises.

Behavioral: Prolonged Exposure Therapy

Interventions

Using a combination of In vivo and Imaginal exposure, Prolonged Exposure therapy aims to treat those with Posttraumatic Stress Disorder.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted to the trauma service at BUMC or Inpatient service at BIR
  • Patients with SCI
  • Patients at least 30 days post injury (to insure proper PTSD diagnosis)
  • Patients ages 18 and older
  • Patients who have a positive PTSD screen using PTSD Symptom Scale - Interview for DSM-5 (PSSI-5)

You may not qualify if:

  • Patients in police custody
  • Non-English speaking
  • Patients with severe cognitive impairment (will be assessed through chart review and with the Cognistat)
  • Patients who are acutely suicidal and/or have been admitted for a suicide attempt
  • Patients who are actively psychotic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor Scott & White Institute for Rehabilitation

Dallas, Texas, 75246, United States

Location

Related Publications (1)

  • Douglas ME, Bennett M, Jones KA, Pogue JR, Chauvette GV, Sikka S, Driver S, Hamilton R, Curcio N, Patel S, Wierzchowski A, Adams M, Thomas EV, Turner E, Leonard K, Carl E, Foreman M, Warren AM, Powers MB. Prolonged exposure for posttraumatic stress disorder following spinal cord injury: A randomized controlled trial. Rehabil Psychol. 2025 Aug;70(3):240-254. doi: 10.1037/rep0000580. Epub 2024 Aug 29.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSpinal Cord Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2018

First Posted

August 10, 2018

Study Start

February 21, 2018

Primary Completion

March 30, 2021

Study Completion

January 6, 2026

Last Updated

January 23, 2026

Record last verified: 2026-01

Locations